141 related articles for article (PubMed ID: 30868837)
21. Linezolid treatment of prosthetic hip Infections due to methicillin-resistant Staphylococcus aureus (MRSA).
Bassetti M; Di Biagio A; Cenderello G; Del Bono V; Palermo A; Cruciani M; Bassetti D
J Infect; 2001 Aug; 43(2):148-9. PubMed ID: 11676523
[TBL] [Abstract][Full Text] [Related]
22. Loss of mecA gene in Staphylococcus epidermidis after prolonged therapy with vancomycin.
Sendi P; Graber P; Zimmerli W
J Antimicrob Chemother; 2005 Oct; 56(4):794-5. PubMed ID: 16141281
[No Abstract] [Full Text] [Related]
23. [Infections of hip and knee endoprostheses. Spectrum of pathogens and the role of multiresistant bacteria].
Zajonz D; Wuthe L; Rodloff AC; Prietzel T; von Salis-Soglio GF; Roth A; Heyde CE; Josten C; Ghanem M
Chirurg; 2016 Apr; 87(4):332-9. PubMed ID: 26661951
[TBL] [Abstract][Full Text] [Related]
24. Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid.
Mancino P; Ucciferri C; Falasca K; Pizzigallo E; Vecchiet J
Scand J Infect Dis; 2008; 40(1):67-73. PubMed ID: 17852941
[TBL] [Abstract][Full Text] [Related]
25. Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis.
Watanabe S; Kawakami Y; Kimura H; Murakami S; Miyamoto H; Takatori S; Suemori K; Tanaka M; Tanaka A; Tanaka K; Tauchi H; Maki J; Araki H; Yamaguchi T
Sci Rep; 2019 Dec; 9(1):18533. PubMed ID: 31811214
[TBL] [Abstract][Full Text] [Related]
26. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections.
Saginur R; Stdenis M; Ferris W; Aaron SD; Chan F; Lee C; Ramotar K
Antimicrob Agents Chemother; 2006 Jan; 50(1):55-61. PubMed ID: 16377667
[TBL] [Abstract][Full Text] [Related]
27. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of ceftaroline against staphylococci from prosthetic joint infection.
Park KH; Greenwood-Quaintance KE; Patel R
Diagn Microbiol Infect Dis; 2016 Feb; 84(2):141-3. PubMed ID: 26602948
[TBL] [Abstract][Full Text] [Related]
30. [Vancomycin resistant Staphylococcus epidermidis caused prosthesis infection. Linezolid and rifampicin healed the complicated infection].
Håkanson A; Fröding I; Ottosson C
Lakartidningen; 2014 Feb; 111(9-10):396-8. PubMed ID: 24570136
[TBL] [Abstract][Full Text] [Related]
31. [The comparative costs of vancomycin treatment versus teicoplanin in osteoarticular infection caused by methicillin-resistant staphylococci].
Pham Dang C; Gouin F; Touchais S; Richard C; Potel G
Pathol Biol (Paris); 2001 Sep; 49(7):587-96. PubMed ID: 11642024
[TBL] [Abstract][Full Text] [Related]
32. Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE).
Knafl D; Tobudic S; Cheng SC; Bellamy DR; Thalhammer F
Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):677-680. PubMed ID: 27896496
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
Vaudaux P; Ferry T; Uçkay I; François P; Schrenzel J; Harbarth S; Renzoni A
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3367-74. PubMed ID: 22833247
[TBL] [Abstract][Full Text] [Related]
34. Genotypic and phenotypic changes of Staphylococcus epidermidis during relapse episodes in prosthetic joint infections.
Ortega-Peña S; Franco-Cendejas R; Aquino-Andrade A; Betanzos-Cabrera G; Sharma A; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Braz J Microbiol; 2020 Jun; 51(2):601-612. PubMed ID: 31828715
[TBL] [Abstract][Full Text] [Related]
35. Clinical Characteristics of Methicillin-resistant Coagulase-negative Staphylococcal Bacteremia in a Tertiary Hospital.
Yamada K; Namikawa H; Fujimoto H; Nakaie K; Takizawa E; Okada Y; Fujita A; Kawaguchi H; Nakamura Y; Abe J; Kaneko Y; Kakeya H
Intern Med; 2017; 56(7):781-785. PubMed ID: 28381743
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid.
Mogenet I; Raetz-Dillon S; Canonge JM; Archambaud M; Bonnet E
Ann Pharmacother; 2004 Jun; 38(6):986-8. PubMed ID: 15113981
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B
Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261
[TBL] [Abstract][Full Text] [Related]
38. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline.
Hamad T; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
APMIS; 2015 Dec; 123(12):1055-60. PubMed ID: 26547372
[TBL] [Abstract][Full Text] [Related]
39. [Staphylococcal infection in the newborn: teicoplanin therapy].
Fanos V; Khoory BJ; Danieli D; Padovani EM
Pediatr Med Chir; 1993; 15(6):579-82. PubMed ID: 8197017
[TBL] [Abstract][Full Text] [Related]
40. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
